Apixaban reduces clot risk in dialysis patients after vascular procedure: Study

A recent study from National Taiwan University Hospital shows that apixaban, a blood-thinning medication, can help prevent blood clots in dialysis patients after a procedure to clear blocked vascular access. Dialysis patients rely on vascular access—like fistulas or grafts—to filter their blood, but clots can form and block these pathways, making dialysis impossible.

Leave A Comment

Your email address will not be published. Required fields are marked *